A Dual-Targeting Delivery System for Effective Genome Editing and In Situ Detecting Related Protein Expression in Edited Cells

被引:54
作者
Liu, Bo-Ya [1 ]
He, Xiao-Yan [1 ]
Xu, Chang [1 ]
Xu, Lei [1 ]
Ai, Shu-Lun [1 ]
Cheng, Si-Xue [1 ]
Zhuo, Ren-Xi [1 ]
机构
[1] Wuhan Univ, Dept Chem, Key Lab Biomed Polymers, Minist Educ, Wuhan 430072, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
CRISPR-CAS9; SYSTEM; GENE DISRUPTION; CANCER; MICE; CDK11; DNA; PROLIFERATION; THERAPEUTICS; TECHNOLOGY; RESISTANCE;
D O I
10.1021/acs.biomac.8b00511
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
One of critical steps in genome editing by CRISPR-Cas9 is to deliver the CRISPR-Cas9 system into targeted cells. In this study, we developed a dual-targeting delivery system based on polymer/inorganic hybrid nanoparticles to realize highly efficient genome editing in targeted tumor cells as well as in situ detection on the related protein expression in edited cells. The CRISPR-Cas9 plasmid for CDK11 knockout was encapsulated in the core of the delivery system composed of protamine sulfate, calcium carbonate, and calcium phosphate by coprecipitation, and functional derivatives of carboxymethyl chitosan (biotinylated carboxymethyl chitosan with biotin ligands and aptamer-incorporated carboxymethyl chitosan with AS1411 ligands) were decorated on the nanovector surface by electrostatic interactions to form the dual-targeting delivery system. On the basis of the tumor cell targeting capability of biotin and AS1411 ligands as well as the nuclear targeting of AS1411, the dual-targeting system can deliver the CRISPR-Cas9 plasmid into the nuclei of tumor cells to realize highly efficient genome editing, resulting in a dramatic decrease (>90%) in CDK11 protein together with the significant downregulation of other proteins involved in tumor development, including an similar to 90% decrease in MMP-9, >40% decrease in VEGF, and similar to 70% decrease in survivin. Using the same vector, molecular beacons can be easily delivered to edited cell nuclei to in situ detect the mRNA level of related proteins (p53 and survivin as typical examples) and mRNA distribution in subcellular organelles. Our strategy can realize effective genome editing and in situ detection on related protein expression simultaneously.
引用
收藏
页码:2957 / 2968
页数:12
相关论文
共 51 条
  • [1] Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
    Bates, Paula J.
    Laber, Damian A.
    Miller, Donald M.
    Thomas, Shelia D.
    Trent, John O.
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2009, 86 (03) : 151 - 164
  • [2] CDK11p58 inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling
    Chi, Yayun
    Huang, Sheng
    Wang, Lei
    Zhou, Ruoji
    Wang, Lisha
    Xiao, Xiuying
    Li, Dali
    Cai, Ying
    Zhou, Xiaoyan
    Wu, Jiong
    [J]. BMC CANCER, 2014, 14
  • [3] CRISPR/Cas9: Transcending the Reality of Genome Editing
    Chira, Sergiu
    Gulei, Diana
    Hajitou, Amin
    Zimta, Alina-Andreea
    Cordelier, Pierre
    Berindan-Neagoe, Ioana
    [J]. MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 7 : 211 - 222
  • [4] SOD2 targeted gene editing by CRISPR/Cas9 yields Human cells devoid of MnSOD
    Cramer-Morales, Kimberly
    Heer, Collin D.
    Mapuskar, Kranti A.
    Domann, Frederick E.
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2015, 89 : 379 - 386
  • [5] Direct Observation of Nanoparticle-Cancer Cell Nucleus Interactions
    Dam, Duncan Hieu M.
    Lee, Jung Heon
    Sisco, Patrick N.
    Co, Dick T.
    Zhang, Ming
    Wasielewski, Michael R.
    Odom, Teri W.
    [J]. ACS NANO, 2012, 6 (04) : 3318 - 3326
  • [6] Viral Vectors: The Road to Reducing Genotoxicity
    David, Rhiannon M.
    Doherty, Ann T.
    [J]. TOXICOLOGICAL SCIENCES, 2017, 155 (02) : 315 - 325
  • [7] Systematic Kinome shRNA Screening Identifies CDK11 (PITSLRE) Kinase Expression Is Critical for Osteosarcoma Cell Growth and Proliferation
    Duan, Zhenfeng
    Zhang, Jianming
    Choy, Edwin
    Harmon, David
    Liu, Xianzhe
    Nielsen, Petur
    Mankin, Henry
    Gray, Nathanael S.
    Hornicek, Francis J.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (17) : 4580 - 4588
  • [8] Targeting Cdk11 in Osteosarcoma Cells Using the CRISPR-cas9 System
    Feng, Yong
    Sassi, Slim
    Shen, Jacson K.
    Yang, Xiaoqian
    Gao, Yan
    Osaka, Eiji
    Zhang, Jianming
    Yang, Shuhua
    Yang, Cao
    Mankin, Henry J.
    Hornicek, Francis J.
    Duan, Zhenfeng
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 2015, 33 (02) : 199 - 207
  • [9] Method for Dual Viral Vector Mediated CRISPR-Cas9 Gene Disruption in Primary Human Endothelial Cells
    Gong, Haixia
    Liu, Menglin
    Klomp, Jeff
    Merrill, Bradley J.
    Rehman, Jalees
    Malik, Asrar B.
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [10] Overcoming doxorubicin resistance of cancer cells by Cas9-mediated gene disruption
    Ha, Jong Seong
    Byun, Juyoung
    Ahn, Dae-Ro
    [J]. SCIENTIFIC REPORTS, 2016, 6